Patent: 9,057,716
✉ Email this page to a colleague
Summary for Patent: 9,057,716
| Title: | Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines |
| Abstract: | The disclosure provides compositions, methods and kits for assessing immunogenicity, potency, or both, of meningococcal capsular saccharide vaccines. The assessment is based upon measurement of binding of a bactericidal antibody to a capsular saccharide component in the vaccine. |
| Inventor(s): | Cristiana Balocchi, Enrico Luzzi, Marilena Paludi, Marzia Monica Giuliani, John Donnelly, Elena Mori |
| Assignee: | GlaxoSmithKline Biologicals SA , GSK Vaccines SRL |
| Application Number: | US13/820,481 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,057,716
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Glaxosmithkline Biologicals | MENVEO | meningococcal (groups a, c, y, and w-135) oligosaccharide diphtheria crm197 conjugate vaccine | Injection | 125300 | February 19, 2010 | 9,057,716 | 2031-09-02 |
| Glaxosmithkline Biologicals | MENVEO | meningococcal (groups a, c, y, and w-135) oligosaccharide diphtheria crm197 conjugate vaccine | Injection | 125300 | October 14, 2022 | 9,057,716 | 2031-09-02 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 9,057,716
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2612148 | ⤷ Start Trial |
| Spain | 2744471 | ⤷ Start Trial |
| United States of America | 2013196352 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2012031271 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
